Hey Brad, I'm curious about your POV now that we're less than month away from year-end. Are you confident Missling will deliver on his promise to shareholders and initiate all 3 trials as planned? I want to be confident, but we were also originally told we could expected a Rett trial by Q1 2017. If FDA developments result in a delay, that's fine, but it's the lack of transparency and communication with investors that's causing me concern.